Find Your Ideal Partner Faster: Advanced Search.
Unlock Strategic Partnerships in Pharma, Biotech & Medtech.
Find Companies Offering or Seeking Collaborations, Services, Products & Technologies.
Save
This Search |
View as Grid
| Order by Recently Added
| Order
by Company Name
- Total Results: 1,352
- Total Pages: 169
Ann Arbor, Michigan, USA
Peptinovo’s platform uses a vitamin E–based linker to temporarily deactivate standard chemotherapeutic agents, allowing them to circulate safely until they reach cancer cells, where the drug is reactivated once inside the cell.
- Licencing Out
We offer our products to other
companies on an 'out-licensing' basis.
- Research and Development
We offer co-development
opportunities.
Partner Profile
Erkrather Str. 401,, Düsseldorf, 40231, Germany
Production of almost any functional protein is possible with the ALiCE® cell-free protein expression system.
- Licencing Out
We offer our products to other
companies on an 'out-licensing' basis.
- Research and Development
We offer co-development
opportunities.
Partner Profile
Venlighedsvej 4, Hørsholm, 2970, Denmark
After prioritizing AttackPoints in silico, we design a panel of oligo-based compounds that can target these RNA regions. Our approach combines innovative design, clinically validated chemistry, proprietary thermodynamic models and selectivity analysis, while remaining chemistry- and mechanism-agnostic. This approach allows us to flexibly fine-tune ASO and siRNA properties to balance potency and selectivity, resulting in well-tolerated compounds.
- Licencing Out
We offer our products to other
companies on an 'out-licensing' basis.
- Research and Development
We offer co-development
opportunities.
Partner Profile
Venlighedsvej 4, Hørsholm, 2970, Denmark
Our proprietary bioinformatic tools enable us to quickly design and implement multiplexed high-throughput assays to assess identified ‘AttackPoints.’ These next-generation sequencing-based assays offer exceptional sensitivity, facilitating the discovery of small molecules that modulate RNA output.
- Licencing Out
We offer our products to other
companies on an 'out-licensing' basis.
- Research and Development
We offer co-development
opportunities.
Partner Profile
Vienna Biocenter 6, Dr. Bohr-Gasse 7, Vienna, A-1030, Austria
A human-first, technology-driven platform that enables faster, cheaper, and more predictive drug discovery.
- Licencing Out
We offer our products to other
companies on an 'out-licensing' basis.
- Research and Development
We offer co-development
opportunities.
Partner Profile
University Of California, Riverside, California, USA
is a new, nanomechanical approach for delivering virtually any gene (or other payload) to the nucleus of cells, en masse, while achieving high transfection efficiency and high cell viability. In doing so, it addresses longstanding limitations inherent to prevailing viral and non-viral delivery techniques, and thus, opens new opportunity for transforming the engineering of ex vivo cell and gene therapies (CGTs).
- Licencing Out
We offer our products to other
companies on an 'out-licensing' basis.
- Research and Development
We offer co-development
opportunities.
Partner Profile
Bengaluru, Karnataka, India
InstaPill® is a differentiated technology platform developed to deliver compelling solutions for on the go dosage convenience with its orally disintegrating tablets (ODTs).
- Licencing Out
We offer our products to other
companies on an 'out-licensing' basis.
- Research and Development
We offer co-development
opportunities.
Partner Profile
2929 Arch Street, Philadelphia, PA 19104, USA
Synecta cell-derived nanoparticles (CDNPs) are produced starting from a mammalian cell line. They are engineered to present defined combinations of signals, including stimulatory signals, co-stimulator ligands, membrane-bound cytokines, and others. Their natural membrane contains adhesion molecules that promote the formation of immunological synapses, driving faster and more robust activation and expansion of functional immune cells for cell therapy.
- Licencing Out
We offer our products to other
companies on an 'out-licensing' basis.
- Research and Development
We offer co-development
opportunities.
Partner Profile
- Total Results: 1,352
- Total Pages: 169
Partnerships in the Pharmaceutical and Medical Device Sectors
Partnership activity between innovators and pharmaceutical service providers are now mainstream activities within our hi-tech industry. This can decrease product development times, bringing products to market quicker while reducing cost.
Our platform provides customised search capabilities to quickly identify activities in the area of pharma technology, relationship type, pharmaceutical form, therapeutic application or drug delivery innovations.
Our partnership data is integrated with our software applications allowing you to quickly identify a suitable partner and qualify and initiate either a development project or supply agreement.
Take the Next Step
We update the partnership's data daily. If you would like to add your company to the platform, you can do so for free ...
Register for an account to add your licensing and partnership details »
Should you have any questions or require further information please contact us ...
Contact the support team »
Check if your company is listed and claim your online profile ...
Search for your company listing »
